{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:46:22Z","timestamp":1794584782310,"version":"4.9.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR-MAD-2022-12,376,779"],"award-info":[{"award-number":["PNRR-MAD-2022-12,376,779"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["CUP C63C22001330006"],"award-info":[{"award-number":["CUP C63C22001330006"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.ijcard.2024.132568","type":"journal-article","created":{"date-parts":[[2024,9,14]],"date-time":"2024-09-14T06:28:06Z","timestamp":1726295286000},"page":"132568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["ICARUS score for predicting peri-procedural bleeding in patients undergoing percutaneous coronary intervention with cangrelor"],"prefix":"10.1016","volume":"417","author":[{"given":"Stefano","family":"Benenati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felice","family":"Gragnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Scalamera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"De Sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Capolongo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Cesaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Annibali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Campagnuolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Silverio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Bellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Centore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Schettino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Bertero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Caretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Rezzaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Veneziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"De Nardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Galasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Menozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Musumeci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Plinio","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Italo","family":"Porto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2024.132568_bb0005","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1016\/j.jacc.2017.08.018","article-title":"Characterization of the average daily ischemic and bleeding risk after primary PCI for STEMI","volume":"70","author":"Giustino","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.carrev.2023.06.014","article-title":"Periprocedural antithrombotic strategies in acute coronary syndromes undergoing percutaneous coronary intervention: have we discarded bivalirudin too soon?","volume":"57","author":"Benenati","year":"2023","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.ijcard.2024.132568_bb0015","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/ehjcvp\/pvad029","article-title":"Bivalirudin plus a high-dose infusion versus heparin in patients with acute coronary syndrome","volume":"9","author":"Galli","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2024.132568_bb0020","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.jacc.2014.08.053","article-title":"Effect of prasugrel pre-treatment strategy in patients undergoing percutaneous coronary intervention for NSTEMI: the ACCOAST-PCI study","volume":"64","author":"Montalescot","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/CIRCULATIONAHA.120.046928","article-title":"Cangrelor, Tirofiban, and chewed or standard Prasugrel regimens in patients with ST-segment-elevation myocardial infarction: primary results of the FABOLUS-FASTER trial","volume":"142","author":"Gargiulo","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2024.132568_bb0030","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1056\/NEJMoa0908629","article-title":"Intravenous platelet blockade with cangrelor during PCI","volume":"361","author":"Bhatt","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2024.132568_bb0035","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","author":"Harrington","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2024.132568_bb0040","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1300815","article-title":"Effect of platelet inhibition with cangrelor during PCI on ischemic events","volume":"368","author":"Bhatt","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2024.132568_bb0045","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(13)61615-3","article-title":"Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data","volume":"382","author":"Steg","year":"2013","journal-title":"Lancet"},{"issue":"38","key":"10.1016\/j.ijcard.2024.132568_bb0050","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132568_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11239-022-02639-z","article-title":"Dual antiplatelet therapy in the contemporary drug-eluting stents era: from vulnerable stents to vulnerable patients","volume":"54","author":"Benenati","year":"2022","journal-title":"J. Thromb. Thrombolysis"},{"key":"10.1016\/j.ijcard.2024.132568_bb0060","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijcard.2022.10.023","article-title":"Revascularization strategies versus optimal medical therapy in chronic coronary syndrome: a network meta-analysis","volume":"370","author":"Galli","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0065","first-page":"10","article-title":"Why percutaneous revascularisation might not reduce the risk of myocardial infarction and mortality in patients with stable CAD?","author":"Benenati","year":"2023","journal-title":"Open Heart"},{"key":"10.1016\/j.ijcard.2024.132568_bb0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/ehjcvp\/pvaa127","article-title":"Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug-eluting stent implantation: a network meta-analysis","volume":"8","author":"Benenati","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2024.132568_bb0075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/ehjcvp\/pvaa001","article-title":"Very short vs. long dual antiplatelet therapy after second generation drug-eluting stents in 35 785 patients undergoing percutaneous coronary interventions: a meta-analysis of randomized controlled trials","volume":"7","author":"Benenati","year":"2021","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2024.132568_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2023.04.051","article-title":"P2Y(12) inhibitor or aspirin monotherapy for secondary prevention of coronary events","volume":"82","author":"Gragnano","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131893","article-title":"Monotherapy with P2Y(12)-inhibitors after dual antiplatelet therapy: filling gaps in evidence","volume":"401","author":"And\u00f2","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0090","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijcard.2022.12.009","article-title":"Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease","volume":"374","author":"Pinxterhuis","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0095","first-page":"13","article-title":"Aspirin in primary prevention: looking for those who enjoy it","author":"Della Bona","year":"2024","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2024.132568_bb0100","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jcin.2016.01.041","article-title":"Impact of access site on bleeding and ischemic events in patients with non-ST-segment elevation myocardial infarction treated with Prasugrel: the ACCOAST access substudy","volume":"9","author":"Porto","year":"2016","journal-title":"JACC Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2024.132568_bb0105","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S0140-6736(21)00533-X","article-title":"Guided versus standard antiplatelet therapy in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis","volume":"397","author":"Galli","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2024.132568_bb0110","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/eurheartj\/ehab836","article-title":"Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials","volume":"43","author":"Galli","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132568_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131157","article-title":"Strategy of dual antiplatelet therapy for patients with ST-elevation myocardial infarction and non-ST-elevation acute coronary syndromes: a systematic review and network meta-analysis","volume":"389","author":"Saito","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131565","article-title":"Incidence and outcomes of high bleeding risk patients with type 1 and type 2 myocardial infarction in a community-based cohort: application of the academic research consortium high bleeding risk criteria","volume":"396","author":"Breen","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0125","first-page":"1","article-title":"Risk of bleeding among Cangrelor-treated patients administered upstream P2Y12 inhibitor therapy: the CAMEO registry","volume":"3","author":"Rymer","year":"2023","journal-title":"JSCAI"},{"key":"10.1016\/j.ijcard.2024.132568_bb0130","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2023.05.025","article-title":"European practice patterns for antiplatelet management in NSTE-ACS patients: results from the REal-world ADoption survey focus on acute antiPlatelet treatment (READAPT) survey","volume":"386","author":"Angiolillo","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41569-023-00953-4","article-title":"Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction","volume":"21","author":"Galli","year":"2024","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0140","doi-asserted-by":"crossref","first-page":"796","DOI":"10.21037\/atm.2019.08.63","article-title":"In-depth mining of clinical data: the construction of clinical prediction model with R","volume":"7","author":"Zhou","year":"2019","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.ijcard.2024.132568_bb0145","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1093\/eurheartj\/ehz372","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention: a consensus document from the academic research consortium for high bleeding risk","volume":"40","author":"Urban","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132568_bb0150","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ehjcvp\/pvaa106","article-title":"PRECISE-DAPT score for bleeding risk prediction in patients on dual or single antiplatelet regimens: insights from the GLOBAL LEADERS and GLASSY","volume":"8","author":"Gragnano","year":"2022","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2024.132568_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2023.01.020","article-title":"Estimation of adverse events associated with P2Y12 receptor inhibitors stratified by academic research consortium for high bleeding risk criteria in acute coronary syndrome","volume":"375","author":"Fujii","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131167","article-title":"Validation of the academic research consortium high bleeding risk definition in Thai PCI registry","volume":"388","author":"Roongsangmanoon","year":"2023","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0165","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2024.132568_bb0170","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcvp\/pvae036","article-title":"Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysis","author":"Galli","year":"2024","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2024.132568_bb0175","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jamacardio.2024.0133","article-title":"Ticagrelor or Clopidogrel monotherapy vs dual antiplatelet therapy after percutaneous coronary intervention: a systematic review and patient-level Meta-analysis","volume":"9","author":"Valgimigli","year":"2024","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0180","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11739-020-02404-1","article-title":"Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry","volume":"16","author":"Gragnano","year":"2021","journal-title":"Intern. Emerg. Med."},{"key":"10.1016\/j.ijcard.2024.132568_bb0185","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcvp\/pvad041","article-title":"Comparison between ticagrelor and clopidogrel in myocardial infarction patients with high bleeding risk- a report from the SWEDEHEART registry","author":"Tjerkaski","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2024.132568_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13451","article-title":"Atrial fibrillation and Alzheimer\u2019s disease: a conundrum","volume":"51","author":"Benenati","year":"2021","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ijcard.2024.132568_bb0195","first-page":"11","article-title":"The incidence and impact of in-hospital bleeding in patients with acute coronary syndrome during the COVID-19 pandemic","author":"Licordari","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.ijcard.2024.132568_bb0200","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ehjcvp\/pvz002","article-title":"Clinical use of cangrelor: nationwide experience from the Swedish coronary angiography and angioplasty registry (SCAAR)","volume":"5","author":"Grimfjard","year":"2019","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"10.1016\/j.ijcard.2024.132568_bb0205","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024513","article-title":"Cangrelor use patterns and transition to Oral P2Y12 inhibitors among patients with myocardial infarction: initial results from the CAMEO registry","volume":"11","author":"Rymer","year":"2022","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2024.132568_bb0210","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jacc.2016.11.017","article-title":"Cangrelor use since FDA approval: a single-center, real-world experience at a tertiary care hospital","volume":"69","author":"Vaduganathan","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2024.132568_bb0215","doi-asserted-by":"crossref","first-page":"oead076","DOI":"10.1093\/ehjopen\/oead076","article-title":"Safety of cangrelor and transition to oral P2Y(12) inhibitors in patients undergoing percutaneous coronary intervention: the ARCANGELO study","volume":"3","author":"De Luca","year":"2023","journal-title":"Eur. Heart J. Open"},{"key":"10.1016\/j.ijcard.2024.132568_bb0220","first-page":"10","article-title":"Cangrelor in older patients undergoing percutaneous coronary intervention: findings from CHAMPION PHOENIX","author":"Cavender","year":"2017","journal-title":"Circ. Cardiovasc. Interv."},{"key":"10.1016\/j.ijcard.2024.132568_bb0225","doi-asserted-by":"crossref","first-page":"e898","DOI":"10.4244\/EIJ-D-21-00181","article-title":"Impact of clinical presentation on bleeding risk after percutaneous coronary intervention and implications for the ARC-HBR definition","volume":"17","author":"Gragnano","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.ijcard.2024.132568_bb0230","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(17)30397-5","article-title":"Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials","volume":"389","author":"Costa","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2024.132568_bb0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131264","article-title":"Impact of using risk scores to guide clinical decisions: do they make a difference?","volume":"389","author":"Gragnano","year":"2023","journal-title":"Int. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324011902?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527324011902?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,16]],"date-time":"2024-10-16T08:52:40Z","timestamp":1729068760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527324011902"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":47,"alternative-id":["S0167527324011902"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132568","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ICARUS score for predicting peri-procedural bleeding in patients undergoing percutaneous coronary intervention with cangrelor","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2024.132568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"132568"}}